Technical Analysis for TBIO - Translate Bio, Inc.

Grade Last Price % Change Price Change
grade B 17.86 2.35% 0.41
TBIO closed up 2.35 percent on Thursday, July 2, 2020, on 1.46 times normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down
Historical TBIO trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
MACD Bearish Signal Line Cross Bearish 2.35%
20 DMA Support Bullish 2.35%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.35%
Calm After Storm Range Contraction 2.35%
Wide Bands Range Expansion 2.35%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Translate Bio, Inc., a clinical-stage messenger RNA (mRNA) therapeutics company, develops medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, which is in Phase I/II clinical trial for the treatment of cystic fibrosis; and MRT5201 to treat ornithine transcarbamylase deficiency. It has a collaboration and license agreement with Sanofi Pasteur Inc. to develop mRNA vaccines for up to five infectious disease pathogens, as well as against COVID-19. The company was formerly known as RaNA Therapeutics, Inc. and changed its name to Translate Bio, Inc. in June 2017. Translate Bio, Inc. was founded in 2011 and is headquartered in Lexington, Massachusetts.
Biotechnology Life Sciences Diseases Cystic Fibrosis Cac 40 Infectious Disease Sanofi Treatment Of Cystic Fibrosis Messenger RNA Arcturus Therapeutics Moderna

Is TBIO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 28.09
52 Week Low 6.8
Average Volume 1,810,515
200-Day Moving Average 10.87
50-Day Moving Average 16.73
20-Day Moving Average 17.54
10-Day Moving Average 19.83
Average True Range 2.37
ADX 19.67
+DI 27.76
-DI 26.97
Chandelier Exit (Long, 3 ATRs ) 20.98
Chandelier Exit (Short, 3 ATRs ) 21.26
Upper Bollinger Band 24.48
Lower Bollinger Band 10.60
Percent B (%b) 0.52
BandWidth 79.14
MACD Line 0.77
MACD Signal Line 0.94
MACD Histogram -0.166
Fundamentals Value
Market Cap 442.74 Million
Num Shares 24.8 Million
EPS -1.30
Price-to-Earnings (P/E) Ratio -13.74
Price-to-Sales 10.57
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.01
Resistance 3 (R3) 20.03 19.35 19.65
Resistance 2 (R2) 19.35 18.80 19.33 19.53
Resistance 1 (R1) 18.60 18.46 18.98 18.58 19.41
Pivot Point 17.92 17.92 18.10 17.90 17.92
Support 1 (S1) 17.17 17.37 17.55 17.15 16.31
Support 2 (S2) 16.49 17.03 16.47 16.19
Support 3 (S3) 15.74 16.49 16.07
Support 4 (S4) 15.72